top of page

CJC-1295 + IPAMORELIN

$99.99Price
Quantity

Product Overview

CJC-1295 and Ipamorelin are frequently paired in research due to their complementary mechanisms of action within the growth hormone (GH) axis. Together, they provide a coordinated approach to stimulating endogenous GH release through both hypothalamic and pituitary signaling pathways.

CJC-1295, a growth hormone releasing hormone (GHRH) analog, works by promoting sustained stimulation of GH release, while Ipamorelin, a selective growth hormone secretagogue, triggers pulsatile GH secretion through ghrelin receptor activation. The combination allows researchers to investigate both sustained and episodic GH signaling within a single model.

This dual-pathway approach makes the blend a widely used option in studies focused on recovery signaling, endocrine balance, and the relationship between growth hormone activity and metabolic processes.



Mechanism of Action

This combination targets two complementary pathways:

  • CJC-1295 (GHRH analog)Stimulates the pituitary to increase growth hormone output over an extended duration

  • Ipamorelin (Ghrelin receptor agonist)Promotes pulsatile growth hormone release via selective receptor activation

Together, these mechanisms enable a more complete model for studying growth hormone dynamics and downstream signaling effects.



Key Research Applications

  • Growth hormone axis stimulation and modeling

  • Recovery and repair pathway research

  • Endocrine system regulation studies

  • Sleep and circadian hormone rhythm research

  • Body composition and metabolic signaling



Product Specifications

  • Total Quantity: 10mg (combined blend)

  • Form: Lyophilized powder

  • Purity: ≥98% (HPLC tested)

  • Appearance: White to off-white powder

  • Storage:

    • Long-term: -20°C

    • Short-term (reconstituted): 2–8°C



Reconstitution Guidance (General Laboratory Use)

This product is supplied in lyophilized form and requires reconstitution prior to use.

  • Use sterile bacteriostatic water

  • Introduce solution slowly along the vial wall

  • Gently swirl—do not shake

Final concentration and protocol should be adjusted based on specific research requirements.



Quality Assurance

  • Third-party tested for purity and identity

  • Batch-specific Certificate of Analysis (COA) available

  • Manufactured in controlled laboratory environments



What’s Included

  • 1 × 10mg CJC-1295 + Ipamorelin blend vial

  • COA access for batch verification



Research Use Notice

For research use only. Not intended for human consumption.

    bottom of page